79 related articles for article (PubMed ID: 22826463)
1. Absolute oral bioavailability and metabolic turnover of β-sitosterol in healthy subjects.
Duchateau G; Cochrane B; Windebank S; Herudzinska J; Sanghera D; Burian A; Müller M; Zeitlinger M; Lappin G
Drug Metab Dispos; 2012 Oct; 40(10):2026-30. PubMed ID: 22826463
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and bioavailability of beta-sitosterol in the beagle dog.
Ritschel WA; Kastner U; Hussain AS; Koch HP
Arzneimittelforschung; 1990 Apr; 40(4):463-8. PubMed ID: 2357248
[TBL] [Abstract][Full Text] [Related]
3. The application of accelerator mass spectrometry to absolute bioavailability studies in humans: simultaneous administration of an intravenous microdose of 14C-nelfinavir mesylate solution and oral nelfinavir to healthy volunteers.
Sarapa N; Hsyu PH; Lappin G; Garner RC
J Clin Pharmacol; 2005 Oct; 45(10):1198-205. PubMed ID: 16172185
[TBL] [Abstract][Full Text] [Related]
4. Absolute bioavailability of intranasal fluticasone furoate in healthy subjects.
Allen A; Down G; Newland A; Reynard K; Rousell V; Salmon E; Scott R
Clin Ther; 2007 Jul; 29(7):1415-20. PubMed ID: 17825692
[TBL] [Abstract][Full Text] [Related]
5. Absolute bioavailability of sitagliptin, an oral dipeptidyl peptidase-4 inhibitor, in healthy volunteers.
Bergman A; Ebel D; Liu F; Stone J; Wang A; Zeng W; Chen L; Dilzer S; Lasseter K; Herman G; Wagner J; Krishna R
Biopharm Drug Dispos; 2007 Sep; 28(6):315-22. PubMed ID: 17575559
[TBL] [Abstract][Full Text] [Related]
6. Analytical determination and pharmacokinetics of robenacoxib in the dog.
Jung M; Lees P; Seewald W; King JN
J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
[TBL] [Abstract][Full Text] [Related]
7. Comparative effect of dietary sitosterol on plasma sterols and cholesterol and bile acid synthesis in a sitosterolemic homozygote and heterozygote subject.
Cobb MM; Salen G; Tint GS
J Am Coll Nutr; 1997 Dec; 16(6):605-13. PubMed ID: 9430090
[TBL] [Abstract][Full Text] [Related]
8. Use of microdosing to predict pharmacokinetics at the therapeutic dose: experience with 5 drugs.
Lappin G; Kuhnz W; Jochemsen R; Kneer J; Chaudhary A; Oosterhuis B; Drijfhout WJ; Rowland M; Garner RC
Clin Pharmacol Ther; 2006 Sep; 80(3):203-15. PubMed ID: 16952487
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
[TBL] [Abstract][Full Text] [Related]
10. Precision and accuracy in the quantitative analysis of biological samples by accelerator mass spectrometry: application in microdose absolute bioavailability studies.
Gao L; Li J; Kasserra C; Song Q; Arjomand A; Hesk D; Chowdhury SK
Anal Chem; 2011 Jul; 83(14):5607-16. PubMed ID: 21627104
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and metabolism of tesaglitazar, a novel dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist, after a single oral and intravenous dose in humans.
Ericsson H; Hamrén B; Bergstrand S; Elebring M; Fryklund L; Heijer M; Ohman KP
Drug Metab Dispos; 2004 Sep; 32(9):923-9. PubMed ID: 15319332
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
[TBL] [Abstract][Full Text] [Related]
13. Comparative pharmacokinetics between a microdose and therapeutic dose for clarithromycin, sumatriptan, propafenone, paracetamol (acetaminophen), and phenobarbital in human volunteers.
Lappin G; Shishikura Y; Jochemsen R; Weaver RJ; Gesson C; Brian Houston J; Oosterhuis B; Bjerrum OJ; Grynkiewicz G; Alder J; Rowland M; Garner C
Eur J Pharm Sci; 2011 Jun; 43(3):141-50. PubMed ID: 21540108
[TBL] [Abstract][Full Text] [Related]
14. Estimating mass balance for inhaled drugs in humans: an example with a VLA-4 antagonist, IVL745.
Rohatagi S; Shah B; Zhang J; Zeng Z; Kirkesseli S; Jensen BK
J Clin Pharmacol; 2004 Apr; 44(4):348-58. PubMed ID: 15051741
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the gastrointestinal absorption and bioavailability of fenofibrate and fenofibric acid in humans.
Zhu T; Ansquer JC; Kelly MT; Sleep DJ; Pradhan RS
J Clin Pharmacol; 2010 Aug; 50(8):914-21. PubMed ID: 20145261
[TBL] [Abstract][Full Text] [Related]
16. Disposition and safety of zonisamide after intravenous and oral single dose and oral multiple dosing in normal hound dogs.
Boothe DM; Perkins J
J Vet Pharmacol Ther; 2008 Dec; 31(6):544-53. PubMed ID: 19000278
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacokinetics of tonapofylline: evaluation of dose proportionality, oral bioavailability, and gender and food effects in healthy human subjects.
Li Z; TenHoor C; Marbury T; Swan S; Ticho B; Rogge M; Nestorov I
J Clin Pharmacol; 2011 Jul; 51(7):1004-14. PubMed ID: 20926751
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of azapropazone following single oral and intravenous doses.
Breuing KH; Gilfrich HJ; Meinertz T; Jähnchen E
Arzneimittelforschung; 1979; 29(6):971-2. PubMed ID: 582795
[TBL] [Abstract][Full Text] [Related]
19. The effects of dose, route, and repeated dosing on the disposition and kinetics of tetrabromobisphenol A in male F-344 rats.
Kuester RK; Sólyom AM; Rodriguez VP; Sipes IG
Toxicol Sci; 2007 Apr; 96(2):237-45. PubMed ID: 17234645
[TBL] [Abstract][Full Text] [Related]
20. Effect of short-term drinking water exposure to dichloroacetate on its pharmacokinetics and oral bioavailability in human volunteers: a stable isotope study.
Schultz IR; Shangraw RE
Toxicol Sci; 2006 Jul; 92(1):42-50. PubMed ID: 16611621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]